Phase II trial of sorafenib in patients with metastatic breast cancer previously exposed to anthracyclines or taxanes: North central cancer treatment group and mayo clinic trial n0336

Alvaro Moreno-Aspitia, Roscoe F. Morton, David W. Hillman, Wiltna L. Lingle, Kendrith M. Rowland, Martin Wiesenfeld, Patrick J. Flynn, Tom R. Fitch, Edith A. Perez

Research output: Contribution to journalArticlepeer-review

133 Scopus citations

Fingerprint Dive into the research topics of 'Phase II trial of sorafenib in patients with metastatic breast cancer previously exposed to anthracyclines or taxanes: North central cancer treatment group and mayo clinic trial n0336'. Together they form a unique fingerprint.

Medicine & Life Sciences